Co-author: Feng-Chang Lin

Unauthenticated ORCID logo https://orcid.org/000-0002-2638-1775

Co-authored publications (2):

Kappelman MD , Lewis JD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF-experienced patients with crohn's disease initiating vedolizumab versus ustekinumab .Dig Dis Sci. 2023; 68 (8) : 3413-20 . doi: 10.1007/s10620-023-07942-0 .
Kappelman MD , Long MD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF experienced patients with ulcerative colitis initiating vedolizumab versus tofacitinib .Crohns Colitis 360. 2023; 5 (3) : otad031 . doi: 10.1093/crocol/otad031 .

Disclaimer

The content of this website, including articles, papers, and any other materials, reflects my personal views and opinions. They do not necessarily represent the views or opinions of my employer, colleagues, or any affiliated organizations. Unless explicitly stated otherwise, this content was generated without the use of any generative AI or large language models (LLMs); all information presented here is solely the result of human input and research.

I may provide links to external websites for convenience or reference, but this does not constitute an endorsement of those sites or the content within them. I am not responsible for the content, accuracy, or reliability of any external websites.

All information shared on this website is for informational purposes only and should not be construed as professional advice.

site admin | credits